These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6627682)

  • 1. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
    Stĕpan JJ; Silinková-Málková E; Havránek T; Formánková J; Zichová M; Lachmanová J; Straková M; Broulik P; Pacovský V
    Clin Chim Acta; 1983 Sep; 133(2):189-200. PubMed ID: 6627682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
    Stĕpán JJ; Lachmanová J; Straková M; Pacovský V
    Bone Miner; 1987 Nov; 3(2):177-83. PubMed ID: 3509796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ; Presl J; Broulík P; Pacovský V
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference intervals for two bone-derived enzyme activities in serum: bone isoenzyme of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TR-ACP).
    Panteghini M; Pagani F
    Clin Chem; 1989 Jan; 35(1):180-1. PubMed ID: 2910567
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
    Nagatoya K; Nishimoto K; Shibahara N; Takahashi T; Kanehara H; Ueno N; Yasuda H; Okada S; Ueda H; Hirai K; Inoue T;
    Clin Exp Nephrol; 2015 Oct; 19(5):939-46. PubMed ID: 25504368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
    Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
    Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal osteopathy in long-term dialysis therapy--comparison of the alkaline phosphatase isoenzyme in bone with histologic findings].
    Hájková B; Erben J; Kubes L; Rouchal J
    Vnitr Lek; 1985 May; 31(5):447-50. PubMed ID: 4024490
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary hyperparathyroidism. I. Comparative biochemical studies on acid and alkaline phosphatases in hyperparathyroidism].
    Gründig E; Czitober H; Maruna RF
    Clin Chim Acta; 1970 Nov; 30(2):331-6. PubMed ID: 4991160
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of dialysis treatment and kidney transplantation on the behavior of bone and small intestine alkaline phosphatase isoenzymes with reference to blood groups and secondary hyperparathyroidism].
    Koall W; Mampel E; Luci V; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Nov; 37(22):745-52. PubMed ID: 6764064
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E; Okuno S; Ichii M; Norimine K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone isoenzyme fraction of alkaline phosphatase in patients undergoing prolonged hemodialysis treatment].
    Bunkova M; Kuleva V
    Vutr Boles; 1978; 17(2):86-9. PubMed ID: 654237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosteal surfaces in hyperparathyroidism: an enzyme cytochemical study on low-temperature-processed, glycol-methacrylate-embedded bone biopsies.
    Bianco P; Bonucci E
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):425-31. PubMed ID: 1750188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and sex dependency of the biochemical indices of bone remodelling.
    Stĕpán JJ; Tesarová A; Havránek T; Jodl J; Formánková J; Pacovský V
    Clin Chim Acta; 1985 Oct; 151(3):273-83. PubMed ID: 4053388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.
    Nakashima A; Yorioka N; Mizutani T; Yamagata Z; Ueno T; Takasugi N
    Nephron Clin Pract; 2005; 99(3):c78-85. PubMed ID: 15665550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.